cancer

Five approaches to effective cancer care managementManaging the care for members with cancer is unlike managing care for other chronic diseases. Here’s five ways to better care for cancer patients.
Four oncology treatment advances to watch
Four oncology treatment advances to watchExperts say a cancer care revolution is here. Here’s a closer look at some advancements in cancer treatments to watch.
Genetic testing: 3 things managed healthcare executives should knowA new survey on genetic testing has surprisingly results on consumer acceptance and impact for healthcare executives.
FDA issues warning over marijuana products claiming cancer cure
FDA issues warning over marijuana products claiming cancer cureFDA warned 4 companies, which are claiming that their products containing cannabidiol, can treat or cure cancer.
Ten ways multiple myeloma treatment is changingAs multiple myeloma treatment improvements continue, it’s important for managed care executives to get out in front of these 10 changes on the horizon.
Unique payer-provider cancer treatment partnershipsUnique partnerships between payers and providers focus on keeping patients out of the hospital and on the road to remission.
Four ways genetic testing is changing cancer careJust as cancer takes many forms, so does genetic testing. Here’s what you need to know.
Managing cancer treatment side effects: What payers should knowMoffitt Cancer Center expert shares her thinking on managing chemotherapy-related side effects.
Personalized and costly, but new ALL treatment offers hopeA new customized therapy for acute lymphoblastic leukemia (ALL) offers high remission rates but at a substantial cost, and only at specialized cancer centers.
Four new treatments for acute myeloid leukemia to watchKey takeaways for healthcare executives from Bruno Medeiros, MD, associate professor of medicine (hematology) at the Stanford University Medical Center and director of Cancer Center Infusion Area Treatment Services at Stanford Cancer Center.